Long-term survival in the randomized trial of drug treatment in mild to moderate hypertension of the Oslo study 1972–3
Authors:
- 1 March 2015
- journal article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 26 (2) , 123-126
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Forskrivning av antihypertensive legemidler 1975 – 2010Tidsskrift for Den norske legeforening, 2012
- Risikofaktorer og dødelighet – oppfølging av Oslo-undersøkelsen fra 1972 – 73Tidsskrift for Den norske legeforening, 2011
- Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk PatientsNew England Journal of Medicine, 2008
- Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialThe Lancet, 2005
- Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialThe Lancet, 2004
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololThe Lancet, 2002
- Coronary heart disease and treatment of hypertension some Oslo study dataThe American Journal of Medicine, 1986
- Treatment of mild hypertension: A five year controlled drug trialThe American Journal of Medicine, 1980
- THE TROMSOØ HEART STUDY: RISK FACTORS FOR CORONARY HEART DISEASE RELATED TO THE OCCURRENCE OF MYOCARDIAL INFARCTION IN FIRST DEGREE RELATIVESAmerican Journal of Epidemiology, 1977
- The Tromsø Heart StudyActa Medica Scandinavica, 1976